论文部分内容阅读
Aim: Doxorubicin (DOX) is an effective chemotherapeutic drug.However, its clinical application may be hampered by dose-dependent cardiotoxicity.The mechanisms of DOX-induced cardiotoxicity are not fully understood, but DOXrelative cardiotoxicity induced by other than those mediating their anticancer effectiveness.In the present study, we use a rat model to test whether the pitavastatin (PTT) can exert protective effects against DOX-induced cardiotoxicity.